Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease

The prevalence of nonalcoholic fatty liver disease (NAFLD) has been significantly increased due to the global epidemic of obesity. The disease progression from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH) is closely linked to inflammation, insulin resistance, and dysbiosis. Althoug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rui Xue, Lianyong Su, Shengyi Lai, Yanyan Wang, Derrick Zhao, Jiangao Fan, Weidong Chen, Phillip B. Hylemon, Huiping Zhou
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
FXR
Acceso en línea:https://doaj.org/article/d7694d2bc7f14f18a0a127caecc01430
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d7694d2bc7f14f18a0a127caecc01430
record_format dspace
spelling oai:doaj.org-article:d7694d2bc7f14f18a0a127caecc014302021-11-25T17:07:20ZBile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease10.3390/cells101128062073-4409https://doaj.org/article/d7694d2bc7f14f18a0a127caecc014302021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2806https://doaj.org/toc/2073-4409The prevalence of nonalcoholic fatty liver disease (NAFLD) has been significantly increased due to the global epidemic of obesity. The disease progression from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH) is closely linked to inflammation, insulin resistance, and dysbiosis. Although extensive efforts have been aimed at elucidating the pathological mechanisms of NAFLD disease progression, current understanding remains incomplete, and no effective therapy is available. Bile acids (BAs) are not only important physiological detergents for the absorption of lipid-soluble nutrients in the intestine but also metabolic regulators. During the last two decades, BAs have been identified as important signaling molecules involved in lipid, glucose, and energy metabolism. Dysregulation of BA homeostasis has been associated with NAFLD disease severity. Identification of nuclear receptors and G-protein-coupled receptors activated by different BAs not only significantly expanded the current understanding of NAFLD/NASH disease progression but also provided the opportunity to develop potential therapeutics for NAFLD/NASH. In this review, we will summarize the recent studies with a focus on BA-mediated signaling pathways in NAFLD/NASH. Furthermore, the therapeutic implications of targeting BA-mediated signaling pathways for NAFLD will also be discussed.Rui XueLianyong SuShengyi LaiYanyan WangDerrick ZhaoJiangao FanWeidong ChenPhillip B. HylemonHuiping ZhouMDPI AGarticlebile acidsgut–liver axisbile acid receptorFXRTGR5S1PR2Biology (General)QH301-705.5ENCells, Vol 10, Iss 2806, p 2806 (2021)
institution DOAJ
collection DOAJ
language EN
topic bile acids
gut–liver axis
bile acid receptor
FXR
TGR5
S1PR2
Biology (General)
QH301-705.5
spellingShingle bile acids
gut–liver axis
bile acid receptor
FXR
TGR5
S1PR2
Biology (General)
QH301-705.5
Rui Xue
Lianyong Su
Shengyi Lai
Yanyan Wang
Derrick Zhao
Jiangao Fan
Weidong Chen
Phillip B. Hylemon
Huiping Zhou
Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
description The prevalence of nonalcoholic fatty liver disease (NAFLD) has been significantly increased due to the global epidemic of obesity. The disease progression from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH) is closely linked to inflammation, insulin resistance, and dysbiosis. Although extensive efforts have been aimed at elucidating the pathological mechanisms of NAFLD disease progression, current understanding remains incomplete, and no effective therapy is available. Bile acids (BAs) are not only important physiological detergents for the absorption of lipid-soluble nutrients in the intestine but also metabolic regulators. During the last two decades, BAs have been identified as important signaling molecules involved in lipid, glucose, and energy metabolism. Dysregulation of BA homeostasis has been associated with NAFLD disease severity. Identification of nuclear receptors and G-protein-coupled receptors activated by different BAs not only significantly expanded the current understanding of NAFLD/NASH disease progression but also provided the opportunity to develop potential therapeutics for NAFLD/NASH. In this review, we will summarize the recent studies with a focus on BA-mediated signaling pathways in NAFLD/NASH. Furthermore, the therapeutic implications of targeting BA-mediated signaling pathways for NAFLD will also be discussed.
format article
author Rui Xue
Lianyong Su
Shengyi Lai
Yanyan Wang
Derrick Zhao
Jiangao Fan
Weidong Chen
Phillip B. Hylemon
Huiping Zhou
author_facet Rui Xue
Lianyong Su
Shengyi Lai
Yanyan Wang
Derrick Zhao
Jiangao Fan
Weidong Chen
Phillip B. Hylemon
Huiping Zhou
author_sort Rui Xue
title Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
title_short Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
title_full Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
title_fullStr Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
title_full_unstemmed Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
title_sort bile acid receptors and the gut–liver axis in nonalcoholic fatty liver disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d7694d2bc7f14f18a0a127caecc01430
work_keys_str_mv AT ruixue bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT lianyongsu bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT shengyilai bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT yanyanwang bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT derrickzhao bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT jiangaofan bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT weidongchen bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT phillipbhylemon bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
AT huipingzhou bileacidreceptorsandthegutliveraxisinnonalcoholicfattyliverdisease
_version_ 1718412744305147904